Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Sep 3;15(9):e0238604. doi: 10.1371/journal.pone.0238604

Difference in pyruvic acid metabolism between neonatal and adult mouse lungs exposed to hyperoxia

Kosuke Tanaka 1, Takaaki Watanabe 1, Junichi Ozawa 1, Masato Ito 1, Nobuhiko Nagano 1, Yukio Arai 1, Fuyu Miyake 1, Shun Matsumura 1, Shingo Kobayashi 1, Ryuta Itakura 1, Fumihiko Namba 1,*
Editor: Ch Ratnasekhar2
PMCID: PMC7470327  PMID: 32881962

Abstract

Objective

Neonatal lungs are more tolerant to hyperoxic injury than are adult lungs. This study investigated differences in the response to hyperoxic exposure between neonatal and adult mouse lungs using metabolomics analysis with capillary electrophoresis time-of-flight mass spectrometry (CE- TOFMS).

Methods

Neonatal and adult mice were exposed to 21% or 95% O2 for four days. Subsequently, lung tissue samples were collected and analyzed by CE-TOFMS. Pyruvate dehydrogenase (PDH) enzyme activity was determined using a microplate assay kit. PDH kinase (Pdk) 1, Pdk2, Pdk3, and Pdk4 mRNA expression levels were determined using quantitative reverse transcription-polymerase chain reaction. Pdk4 protein expression was quantified by Western blotting and Pdk4 protein localization was evaluated by immunohistochemistry.

Results

Levels of 3-phosphoglyceric acid, 2-phosphoglyceric acid, phosphoenolpyruvic acid, and lactic acid were significantly elevated in the lungs of hyperoxia-exposed versus normoxia-exposed adult mice, whereas no significant differences were observed with hyperoxia exposure in neonatal mice. PDH activity was reduced in the lungs of adult mice only. Pdk4 mRNA expression levels after hyperoxic exposure were significantly elevated in adult mice compared with that in neonatal mice. Conversely, gene expression levels of Pdk1, Pdk2, and Pdk3 did not differ after hyperoxic exposure in either neonatal or adult mice. Pdk4 protein levels were also significantly increased in adult mouse lungs exposed to hyperoxia and were localized mainly to the epithelium of terminal bronchiole.

Conclusions

Specific metabolites associated with glycolysis and gluconeogenesis were altered after hyperoxia exposure in the lungs of adult mice, but not in neonates, which was likely a result of reduced PDH activity due to Pdk4 mRNA upregulation under hyperoxia.

Introduction

Exposure to high oxygen (O2) level induces lung injury in newborn rodents, which are often used as an animal model of neonatal chronic lung disease due to its pathological similarity to bronchopulmonary dysplasia that occurs in humans [1]. Furthermore, adult mice exposed to hyperoxia in the neonatal period exhibit persistent alveolar simplification, increased lung compliance, increased sensitivity to viral infection, and pulmonary vascular disease [2, 3]. Hyperoxia also causes acute lung injury and acute respiratory distress syndrome in adult mice and humans [4]. Although most neonatal rodents survive hyperoxia-induced lung injury, adults die within 1 week of exposure to high O2 concentrations [5]. Elevated antioxidant enzyme activity [6] and decreased superoxide-generating capacity [7] have been proposed as underlying mechanisms for the enhanced tolerance to hyperoxia in newborn animals, the exact cause is yet to be clarified.

Pyruvate dehydrogenase (PDH) catalyzes the oxidative decarboxylation of pyruvate to produce acetyl-coenzyme A (acetyl-CoA). PDH activity is negatively regulated by PDH kinase (PDK). There are four known tissue-specific PDK isoenzymes: PDK1and PDK 2, which are expressed in most cells; PDK3, which is expressed mainly in the testes: and PDK4, which is expressed primarily in muscle during metabolic stress [8]. PDK4 is located in the mitochondrial matrix and regulates the rate of glucose oxidation and fatty acid metabolism in mammalian cells through direct inhibition of the PDH complex. In 1980’s, Kimura, et al. reported that total PDH activity was 45% lower in the lungs of neonatal rats exposed to 100% O2 for the first 6 days of life than that in normoxic controls [9]. However, the role of pyruvate metabolism differences between newborn and adult mice in the effects of hyperoxic exposure has not been investigated.

Metabolites, end products of cellular regulatory processes, play important biological roles and provide a functional readout of cellular biochemistry that is important to identifying metabolic pathways related to disease processes. Metabolomics is an analytical technique in systems biology used to characterize low-molecular-weight metabolites in biological sample such as cells, tissues, and biofluids under a particular condition. This technique has been widely used to identify novel biomarkers and gain insight into the mechanisms that underlie various diseases [10, 11]. Few metabolomic analyses were performed on mouse lungs exposed to hyperoxia, and none have been conducted to elucidate differences in susceptibility to high concentrations of O2 between neonatal and adult mice. Therefore, in this study, we aimed to investigate differences in the response to hyperoxic exposure between neonatal and adult mouse lungs using metabolomic analysis with capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS).

Materials and methods

Animals

All procedures and protocols were approved by the Animal Care and Use Committee of Saitama Medical University (Permit no. 1691). C57BL/6J mice (SLC, Hamamatsu, Shizuoka, Japan) were maintained on a 12-h light, 12-h dark cycle with ad libitum access to food and water. All experimental procedures were performed in accordance with the National Institutes of Health Guidelines for Laboratory Animal Care, in addition to our institutional guidelines. Neonatal pups (<12 hours old) and adult mice (8 weeks old) were randomly assigned to normoxia (room air) or hyperoxia (95% O2). Details of the hyperoxic exposure and lung tissue collection were described in our previous report [12]. Briefly, mice were exposed to hyperoxia for 96 h in a chamber. Mice were anesthetized with an intraperitoneal injection of pentobarbital (50 mg/kg), and the right lung was excised, snap-frozen with liquid nitrogen, and stored at −80°C for further analysis. All efforts were undertaken to minimize suffering.

Metabolite extraction

Metabolite extraction and metabolomic analysis were conducted at Human Metabolome Technologies (HMT) (Tsuruoka, Yamagata, Japan). Neonatal mice of unknown sex (<12 h old, n = 8) and adult male and female mice (8 weeks old, n = 4 each) were exposed to normoxia or hyperoxia for 96 h. Approximately 50 mg of frozen lung tissue from four animals in each group was immersed into 1500 μL of 50% acetonitrile/Milli-Q water containing internal standards (Solution ID: 304–1002, HMT) at 0 °C to inactivate enzymes. The tissue was homogenized five times at 1500 rotation per minutes for 120 s using a tissue homogenizer (Micro Smash MS100R, Tomy Digital Biology Co., Ltd., Tokyo, Japan), and the homogenate was centrifuged at 2300g at 4°C for 5 min. Subsequently, 800 μL of supernatant was filtered by centrifugation through a Millipore 5-kDa cutoff filter at 9100g at 4°C for 120 min to remove proteins. The filtrate was concentrated by centrifugation and resuspended in 50 μL Milli-Q water for CE-TOFMS analysis at HMT.

Metabolomic analysis

Metabolomic analysis was conducted by the BasicScan package by HMT using CE-TOFMS based on previously described methods (9, 10). Briefly, CE-TOFMS analysis was performed using an Agilent CE system equipped with an Agilent 6210 TOFMS, Agilent 1100 isocratic high-performance liquid chromatography HPLC pump, Agilent G1603A CE-MS adapter kit, and Agilent G1607A CE-ESI-MS sprayer kit (Agilent Technologies, Waldbronn, Germany). The systems were controlled by Agilent G2201AA ChemStation software version B.03.01 for CE (Agilent Technologies) and connected by a fused silica capillary (50 μm i.d. × 80 cm total length) with commercial electrophoresis buffer (H3301-1001 and H3302-1021 for cation and anion analyses, respectively, HMT) as the electrolyte. The spectrometer was scanned from m/z 50–1000 (9). Peaks were extracted using MasterHands, an automatic integration software (Keio University, Tsuruoka, Yamagata, Japan), to obtain peak information including m/z, peak area, and migration time (11). Peaks were annotated according to the HMT metabolite database based on m/z values with migration times. Areas of the annotated peaks were then normalized on the basis of internal standard levels and sample amounts to obtain relative level for each metabolite. In annotation, mass error was limited within ±10ppm of theoretical value and migration tome was limited within ±0.5 minutes of the database.

Pyruvate dehydrogenase enzyme activity assay

PDH enzymatic activity was measured using a commercially available PDH enzyme activity microplate assay kit (ab109902; Abcam, Cambridge, UK) following the manufacturer’s instructions. Briefly, lung tissue extracts (800 μg) from neonatal mice (<12 h old, n = 24) and adult male and female mice (8 weeks old, n = 12 each) exposed to normoxia or hyperoxia for 96 h were loaded into a 96-well plate for PDH activity assay. The PDH enzyme complex components were immunocaptured by monoclonal antibodies coated on the wall of each well, and PDH enzymatic activity was determined on the basis of the production of reduced nicotinamide adenine dinucleotide coupled to the reduction of the reporter dye WST-1 to the color yellow. Vmax and absorbance of the reporter dye in each well were measured at 450 nm at room temperature using a kinetic program for 30 min (Corona Grating Microplate Reader SH-9000, Corona Electric, Ibaraki, Japan).

Gene expression analysis

Total RNA was extracted from excised lungs of neonatal mice (<12 hours old, n = 12) and adult male and female mice (8 weeks old, n = 6, each) exposed to normoxia or hyperoxia for 96 h as previously described [13], and mRNA expression levels of Pdk1 (Assay ID: Mm00554300_m1), Pdk 2 (Assay ID: Mm00446681_m1), Pdk 3 (Assay ID: Mm00455220_m1), and Pdk 4 (Assay ID: Mm01166879_m1; Applied Biosystems, Tokyo, Japan) were evaluated by polymerase chain reaction (PCR) using the TaqMan® fluorogenic detection system. Because hyperoxia alters four of the housekeeping genes recommended by the manufacturer (Hprt1, Hsp90ab1, Gapdh, and Actb), we used β-glucuronidase (Mm01197698_m1) for normalization after confirming that its expression levels were comparable among all conditions.

Western blot

Western blot analyses were performed to evaluate PDK4 protein levels. Lung tissues excised from neonatal mice (<12 h old, n = 12) and adult male mice (8 weeks old, n = 12) exposed to normoxia or hyperoxia for 96 h were homogenized in tissue extraction buffer (78510; Thermo Fisher Scientific, Waltham, MA, USA). The lysates were clarified by centrifugation at 10,000 g for 5 min. Protein samples (50 μg) were separated using SDS/PAGE and transferred to membranes. The membranes were blocked and incubated with the anti-PDK4 primary antibody (1:500; ab172920; Abcam) or anti-β-actin antibody (1:5000; GTX26276; GeneTex, Irvine, CA, USA), followed by horseradish peroxidase (HRP)-labeled secondary antibodies. Chemiluminescence was detected using the Amersham ECL Prime Western blotting detection reagent (GE Healthcare, Chicago, IL, USA) with a digital imaging system (Bio-Rad ChemiDoc XRS+; Bio-Rad Laboratories, Hercules, CA, USA).

Immunohistochemistry

Formalin-fixed paraffin-embedded sections of lungs excised from neonatal mice (<12 h old, n = 12) and adult male mice (8 weeks old, n = 12) exposed to normoxia or hyperoxia for 96 h were deparaffinized and rehydrated. The sections were processed with Antigen Unmasking Solution pH6 (H-3300; Dako, Glostrup, Denmark) and immersed in 3% hydrogen peroxide solution for 30 min. The sections were incubated with an anti-PDK4 primary antibody (1:200; PDK4(12949-1-AP); ProteinTech, Rosemont, IL, USA) for 1 h at room temperature. Immunoreactivity was detected using the Envision Kit with a HRP-labelled anti-rabbit IgG secondary antibody (K4003; Dako). Sections were counterstained with Mayer’s hematoxylin.

Statistical analysis

Group comparisons were performed using Welch’s t test. Principal component analysis (PCA) and hierarchical cluster analysis (HCA) were performed using two proprietary software packages by HMT called SampleStat and PeakStat, respectively. Detected metabolites were plotted on metabolic pathway maps using the VANTED software [14].

Analyses of PDH activity, gene expression, and protein expression were conducted using the R statistical package (version 3.5.2), and values were represented as means ± standard error of the mean (SEM). The null hypothesis was tested by unpaired Student’s t test for comparisons between two treatment groups. A p value < 0.05 was considered statistically significant.

Results

Effects of hyperoxic exposure on metabolites in the newborn and adult mouse lungs

Metabolites extracted from newborn and adult mouse lungs exposed to normoxia or hyperoxia were identified using metabolomics. There were 258 peaks identified and quantified with metabolite standards by matching closest m/z values and normalized migration times. Of these, 130 and 128 were cations and anions, respectively. The levels of 63 and 112 metabolites in the newborn and adult mouse lungs, respectively, were significantly altered by hyperoxic exposure.

The levels of 114 metabolites were significantly differed between the newborn and adult mouse lungs under normoxic condition, whereas the levels of 99 metabolites were significantly different between the newborn and adult mouse lungs after hyperoxic exposure. Four major clusters were distinguished by the HCA (Fig 1), and these clusters were coincident with the four groups from which the lungs were obtained: room air newborn, high O2 concentration newborn, room air adult, and high O2 concentration adult groups. The PCA revealed that the metabolic profiles of the newborn and adult mouse lungs were clearly distinct from each other (first principal component), as were the metabolic profiles of the mouse lungs exposed to hyperoxia and normoxia (second principal component; Fig 2). The cumulative contribution rate of these two major principal components was 59.5%.

Fig 1. Visualization of the profiles of the detected metabolites uasing a heat map.

Fig 1

Columns represent individual mice, and row represent specific metabolites. The color scale from green to red indicates relative changes in the levels of the detected metabokites. Red indicates that the relative level of the metabolite is higher than the average, and green indicates that the relative level of the metabolite is lower than the average. Lungs were obtained from four different groups of mice: room air newborn, high O2 concentration newborn, room air adult, and high O2 concentration adult groups. The four major clusters distinguished by HCA are coincident with the four groups.

Fig 2. Principal component analysis of the metabolomic dataset of the four groups.

Fig 2

Percentage on the axes represent the contribution rate of the first (PC1) and second (PC2) principal components. PC1 and PC2 had contribution ratios of 35.4% and 24.5%, respectively, and were sufficient to distinguish the four groups. Ellipses are graphical representations of groups without any statistical support. NAir, newborn, room air; NO2, newborn hyperoxia; AAir, adult room air; AO2, adult, hyperoxia; PC, principal component.

Metabolic pathways altered in hyperoxia-induced lungs differ between adults and neonates

The peaks detected by CE-TOFMS were classified into glycolysis/gluconeogenesis, pentose phosphate pathway, tricarboxylic acid (TCA) cycle, urea cycle, purine/pyrimidine metabolism, coenzyme metabolism, and various amino acid metabolic pathways based on the candidate compounds (S1 Fig). On the basis of the KEGG pathway database, metabolic pathways and functional classifications were constructed. Among the numerous pathways identified, we focused on the glycolysis-citric acid circuit because many metabolites constituting this circuit were highly loaded in both the first and second principal components in the PCA (S1 Table).

Higher levels of 3- phosphoglyceric acid (PG), 2-PG, phosphoenolpyruvate (PEP), and lactic acid, which are involved in the glycolysis and gluconeogenesis pathways were found in the hyperoxia-exposed adult lungs than in the hyperoxia-exposed neonatal lungs. Hyperoxia increased the levels of these metabolites in the adult mouse lungs, whereas hyperoxia had no significant effect on their levels in neonatal mouse lungs (Fig 3).

Fig 3. Metabolomic data map of the glycolysis and glyconeogenesis pathways in the neonatal and adult mouse lungs.

Fig 3

Vertical axes show the detected average value with standard deviation (error bar) for each comparison, and the groups are arranged from the left in the following order: room air newborn (blue), high O2 concentration newborn (bright red), room air adult (purple), and high O2 concentration adult (light red). All metabolic data are presented as means ± standard deviation from biological triplicate samples.

Reduced PDH enzymatic activity in the hyperoxia-exposed adult mouse lungs

On the basis of the metabolomics analysis, we speculated that the differences in the glycolysis-citric acid metabolic pathway between the newborn and adult mouse lungs exposed to hyperoxia stemmed from differences in the conversion of pyruvic acid to acetyl-CoA. As this oxidative decarboxylation reaction is facilitated by PDH, we quantified its enzymatic activity (Fig 4) and determined that it was significantly reduced in the hyperoxia-exposed than in the normoxia-exposed adult mouse lungs. However, a similar reduction in PDH enzymatic activity due to hyperoxia exposure was not detected in the newborn lungs.

Fig 4. Pyruvate dehydrogenase enzymatic activity levels in the neonatal and adult mouse lungs exposed to normoxia or hyperoxia.

Fig 4

The vertical axis shows PDH enzymatic activity (Δ mOD450/min). Animals were exposed to normoxia (open bars) or hyperoxia (filled bars). Data are shown as means ± SEM. Comparisons between groups were performed using a t test. * p < 0.05; ** p < 0.01. Air: normoxia; O2: hyperoxia; SEM: Standard error of the mean.

Differences in Pdk4 mRNA and protein expression levels in hyperoxia-exposed lungs

PDK negatively regulates PDH that catalyzes the oxidative decarboxylation of pyruvate to produce acetyl CoA. Therefore, we quantified the mRNA expression levels of Pdk1, Pdk2, Pdk3, and Pdk4 by real-time PCR in the neonatal and adult mouse lungs exposed to either normoxia or hyperoxia (Fig 5). Lung expression of Pdk4 was higher in adult mice than in neonates under normoxia, and expression of Pdk4 was increased after exposure to hyperoxia in both groups. Additionally, the expression of Pdk4 was lower in hyperoxia-exposed neonate lungs than in normoxia-exposed adult lungs. In contrast, no significant changes were observed in the lung expression levels of Pdk1, Pdk2, or Pdk3 in newborn or adult mice after hyperoxic exposure. Western blotting confirmed the increase Pdk4 protein levels in the adult mouse lungs exposed to hyperoxia (Fig 6A and 6B). We also evaluated the expression and localization of Pdk4 protein in the lungs by immunohistochemistry. Immunohistochemical staining was observed mainly in the epithelium of terminal bronchiole in all four groups (Fig 6C).

Fig 5. Expression levels of (A) Pdk1, (B) Pdk2, (C) Pdk3, and (D) Pdk4 in the lungs quantified by real-time PCR.

Fig 5

Data are shown as means ± SEM. Comparisons between groups were performed using a t test. * p < 0.05; ** p < 0.01. Air: normoxia; O2: hyperoxia; SEM: Standard error of the mean.

Fig 6. Expression levels of Pdk4 protein in the lungs quantified by Western blot (A,B) and immunohistochemical localization of Pdk4 protein in the lung (C).

Fig 6

(A) The arrow indicates a band of Pdk4 protein. (B) The vertical axis shows the relative expression of Pdk4 protein. Data are shown as means ± SEM. Comparisons between groups were performed using a t test. * p < 0.05; ** p < 0.01. Air: normoxia; O2: hyperoxia; SEM: Standard error of the mean. (C) Immunostaining was observed in the epithelium of terminal bronchiole in all four groups (brown). Scale bar = 100 μm.

Discussion

This is the first study to identify differences in the metabolic profiles of newborn and adult mouse lungs after hyperoxic exposure using metabolomics analysis. Our analyses revealed major differences between newborn and adult mice in metabolites constituting the glycolysis-citric acid circuit, including 3-PG, 2-PG, PEP, and lactic acid. We also found that the lung mRNA expression and protein levels of Pdk4 were upregulated after hyperoxic exposure in adult mice, which led to reduced PDH activity in the lung; this was not observed in neonates. These findings partially explain the differences in susceptibility to hyperoxia between adults and neonates.

Several studies have investigated the differences in O2 tolerance between newborn and adult animals. Ischiropoulos, et al. studied neonatal and adult rats exposed to hyperoxia and reported that O2 tolerance in neonates can be explained in part by a favorable balance between antioxidant defenses and subcellular superoxide-generating capacity [7]. Another group observed the ability of the neonatal type II cell to respond to hyperoxia with an early increase in antioxidant enzyme activity of superoxide dismutase, which may contribute to the enhanced O2 tolerance of the neonatal rat [15]. Furthermore, compared with adult rodents, newborn rodents reportedly have a diminished pulmonary inflammatory response due to differences in chemokine levels [16, 17]. L-selectin on neutrophils was lower in neonatal rats than in adult rats, and soluble L-selectin was higher in the air-exposed neonate and tended to be higher after hyperoxic exposure. This suggested that both lower surface L-selectin and higher soluble L-selectin might play a role in the diminished pulmonary inflammatory response in the neonatal rat after hyperoxia [17]. However, there no studies have focused on metabolic changes in lungs exposed to hyperoxia using a metabolomics approach to elucidate the differences in O2 tolerance between newborns and adults.

The metabolomics analysis in adult mice revealed increases in the levels of glycolysis pathway metabolites, with a decrease in acetyl CoA levels. Glycolysis involves 10 reactions and converts glucose into pyruvic acid, producing four molecules of adenosine triphosphate and two molecules of reduced nicotinamide adenine dinucleotide [18]. In the last steps of glycolysis, 3-PG is converted into pyruvate via the synthesis of 2-PG and PEP, with the concomitant conversion of adenosine diphosphate into adenosine triphosphate. Subsequently, pyruvate is converted into acetyl CoA by PDH, leading to an increased influx of acetyl CoA into the TCA cycle. As oxidative phosphorylation in the mitochondrial electron transport chain and glycolysis are the energy-yielding pathways in cells, previous studies have focused on the effects of hyperoxia on glycolysis and mitochondrial metabolism in adults [1927].

Although the effect of hyperoxia on glycolysis is not well understood, numerous studies have demonstrated an increase in the rate of glycolysis during hyperoxia [19, 25, 26]. Simon et al. showed that the activity levels of important glycolytic pathway enzymes such as glyceraldehyde-3-phosphate dehydrogenase, pyruvate kinase, and phosphofructokinase did not decrease in hyperoxia [26]; these finding are consistent with the results of our metabolomic analysis. The effect of hyperoxia on mitochondrial metabolism, albeit investigated previously [2023], is also not well understood. Bassett et al. assessed mitochondrial activity and changes in glucose metabolism in the perfused rat lung after hyperoxic exposure. They reported lower maximal rates of pyruvate catabolism and increased lactic acid formation upon perfusion with glucose after hyperoxic exposure. These results demonstrated that mitochondrial metabolism of pyruvate, rather than glycolysis, is potentially the initial step in O2-induced inhibition of energy metabolism [20, 21] and are consistent with the findings of our metabolomic analysis. Bassett et al. also examined the effect of in vivo O2 exposure on the lung mitochondrial energy-generating pathways and demonstrated that, although baseline metabolic rates were sustained during the first 24–30 h of exposure, maximal pyruvate and palmitate carbon dioxide production was compromised. The authors concluded that, in addition to the PDH complex, nicotinamide adenine dinucleotide-linked isocitrate dehydrogenase was a potential site of O2-induced mitochondrial damage [22]. However, our analysis did not reveal similar findings. In addition to alterations in the TCA cycle, Kumuda et al. showed that hyperoxia caused dysfunction of both mitochondrial complexes I and II and disrupted mitochondrial electron transport chain function [23].

In the metabolomic analysis, we identified differences in the levels of metabolites that constitute the glycolysis-citric acid circuit, including 3-PG, 2-PG, PEP, and lactic acid, between the newborn and adult mouse lungs after hyperoxic exposure. Our analysis demonstrated increased levels of metabolites upstream of the reaction that converts pyruvate to acetyl-CoA in the hyperoxia-exposed adult mouse lungs. These differences were not observed in the neonatal mouse lungs.

We hypothesized that the increased levels of these metabolites in the adult mouse lungs were due to reduced PDH activity and confirmed this in the adult mouse lung exposed to hyperoxia. This effect was not observed in the newborn lungs exposed to hyperoxia when compared with their normoxic counterparts. This suggests that hyperoxia perturbed metabolic pathways and induced increased glycolysis in the adult mouse lungs, which is in agreement with the findings of a previous study [28].

In the current study, we quantified the mRNA expression levels of the four PDK isoenzymes and found that the lung expression levels of Pdk4 were significantly increased in both the neonates and the adults after hyperoxic exposure. However, compared with those in the neonatal mice, remarkable increases in Pdk4 expression were observed in the adult mouse lungs after hyperoxic exposure. This suggests that increased Pdk4 negatively modulated PDH enzymatic activity, resulting in the accumulation of 3-PG, 2-PG, PEP, and lactic acid in the adult mouse lungs exposed to hyperoxia.

Lingappan et al. compared sex-specific differences in the pathophysiology of hyperoxic lung injury [29] based on observed sex-specific differences in susceptibility to hyperoxic lung injury in both animal models and epidemiological studies of human patients. Males with acute respiratory distress syndrome have a higher mortality rate than have females, and male sex is an independent risk factor for the development of bronchopulmonary dysplasia in premature neonates. The authors performed microarray analysis of the lungs after hyperoxia exposure and demonstrated that the Pdk4 gene was upregulated in males. This result is consistent with our findings suggesting that increased PDK4 expression might confer susceptibility to hyperoxia.

We speculate that the reduced PDH activity in the adult mouse lungs due to elevated expression of Pdk4 might lead to a decrease in the rate of transition from glycolysis to the TCA cycle, resulting in reduced energy production via oxidative phosphorylation. This limitation of energy supply to the lung cells might be one of the underlying reasons for vulnerability to hyperoxia in adult mice.

In conclusion, we demonstrated that specific metabolites related to glycolysis and gluconeogenesis, including 3-PG, 2-PG, PEP, and lactic acid, were increased in the adult but not neonatal mouse lungs after hyperoxic exposure. These increased metabolite levels in the adult mouse lungs might be due to reduced PDH activity, which was negatively regulated by Pdk4 upregulation under hyperoxia. These result provide a possible explanation for the difference in tolerance to hyperoxia between neonatal and adult mice and an insight into potential intervention approaches for preventing hyperoxia-induced acute lung injury and acute respiratory distress syndrome.

Supporting information

S1 Fig. Metabolomic data map of the all metabolic pathway detected in the neonatal and adult mouse lungs.

For all metabolite graphs, the vertical axis shows the detected average value with standard deviation (error bar) for each comparative group, and the groups are arranged from the left in the following order: room air newborn (blue), high O2 concentration newborn (bright red), room air adult (purple), and high O2 concentration adult groups (light red). All metabolic data are presented as means ± standard deviation from biological triplicate samples.

(PPTX)

S2 Fig

(JPG)

S3 Fig

(JPG)

S1 Table. Factor loadings of the principal component analysis (PCA).

Metabolites constituting glycolysis-citric acid circuit are highlighted with grey background.

(XLSX)

Acknowledgments

The authors thank Dr. Shigeo Tojo and Human Metabolome Technologies for the metabolomic analysis and technical advices and Ms. Kikumi Matsuoka (Departments of Biomedical Sciences, Saitama Medical Center, Saitama Medical University) for technical assistance with the experiments.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This research was supported by the Saitama Medical University Internal Research Grant (Grant no. 17-C-1-2) (SK) and Saitama Medical University Young Doctors Educational Grant (Grant no. 29-F-1-01) (RI) from Saitama Medical University, a grant from Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (Grant no. 29-7) (FN), and Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (Grant no. 18K15729) (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Buczynski BW, Maduekwe ET, O’Reilly MA. The role of hyperoxia in the pathogenesis of experimental BPD. Seminars in perinatology. 2013;37(2):69–78. Epub 2013/04/16. 10.1053/j.semperi.2013.01.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.O’Reilly MA, Yee M, Buczynski BW, Vitiello PF, Keng PC, Welle SL, et al. Neonatal oxygen increases sensitivity to influenza A virus infection in adult mice by suppressing epithelial expression of Ear1. The American journal of pathology. 2012;181(2):441–51. Epub 2012/06/09. 10.1016/j.ajpath.2012.05.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Namba F, Ogawa R, Ito M, Watanabe T, Dennery PA, Tamura M. Sex-related differences in long-term pulmonary outcomes of neonatal hyperoxia in mice. Exp Lung Res. 2016;42(2):57–65. Epub 2016/04/14. 10.3109/01902148.2016.1141264 . [DOI] [PubMed] [Google Scholar]
  • 4.Kallet RH, Matthay MA. Hyperoxic acute lung injury. Respiratory care. 2013;58(1):123–41. Epub 2012/12/29. 10.4187/respcare.01963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Frank L, Bucher JR, Roberts RJ. Oxygen toxicity in neonatal and adult animals of various species. Journal of applied physiology: respiratory, environmental and exercise physiology. 1978;45(5):699–704. Epub 1978/11/01. 10.1152/jappl.1978.45.5.699 . [DOI] [PubMed] [Google Scholar]
  • 6.Li Q, Wall SB, Ren C, Velten M, Hill CL, Locy ML, et al. Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation. American journal of respiratory cell and molecular biology. 2016;55(3):419–28. Epub 2016/04/19. 10.1165/rcmb.2015-0228OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ischiropoulos H, Nadziejko CE, Kumae T, Kikkawa Y. Oxygen tolerance in neonatal rats: role of subcellular superoxide generation. Am J Physiol. 1989;257(6 Pt 1):L411–20. Epub 1989/12/01. 10.1152/ajplung.1989.257.6.L411 . [DOI] [PubMed] [Google Scholar]
  • 8.Yuan K, Shao NY, Hennigs JK, Discipulo M, Orcholski ME, Shamskhou E, et al. Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension. The American journal of pathology. 2016;186(9):2500–14. Epub 2016/07/28. 10.1016/j.ajpath.2016.05.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kimura RE, Thulin GE, Wender D, Warshaw JB. Decreased oxidative metabolism in neonatal rat lung exposed to hyperoxia. Journal of applied physiology: respiratory, environmental and exercise physiology. 1983;55(5):1501–5. Epub 1983/11/01. 10.1152/jappl.1983.55.5.1501 . [DOI] [PubMed] [Google Scholar]
  • 10.Wakayama M, Hirayama A, Soga T. Capillary electrophoresis-mass spectrometry. Methods Mol Biol. 2015;1277:113–22. Epub 2015/02/14. 10.1007/978-1-4939-2377-9_9 . [DOI] [PubMed] [Google Scholar]
  • 11.Uetaki M, Tabata S, Nakasuka F, Soga T, Tomita M. Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress. Sci Rep. 2015;5:13896 Epub 2015/09/10. 10.1038/srep13896 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ito M, Nagano N, Arai Y, Ogawa R, Kobayashi S, Motojima Y, et al. Genetic ablation of Bach1 gene enhances recovery from hyperoxic lung injury in newborn mice via transient upregulation of inflammatory genes. Pediatr Res. 2017;81(6):926–31. Epub 2017/01/19. 10.1038/pr.2017.17 . [DOI] [PubMed] [Google Scholar]
  • 13.Namba F, Go H, Murphy JA, La P, Yang G, Sengupta S, et al. Expression level and subcellular localization of heme oxygenase-1 modulates its cytoprotective properties in response to lung injury: a mouse model. PLoS One. 2014;9(3):e90936 10.1371/journal.pone.0090936 ; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Junker BH, Klukas C, Schreiber F. VANTED: a system for advanced data analysis and visualization in the context of biological networks. BMC bioinformatics. 2006;7:109 Epub 2006/03/08. 10.1186/1471-2105-7-109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Keeney SE, Cress SE, Brown SE, Bidani A. The effect of hyperoxic exposure on antioxidant enzyme activities of alveolar type II cells in neonatal and adult rats. Pediatr Res. 1992;31(5):441–4. Epub 1992/05/01. 10.1203/00006450-199205000-00005 . [DOI] [PubMed] [Google Scholar]
  • 16.D’Angio CT, Johnston CJ, Wright TW, Reed CK, Finkelstein JN. Chemokine mRNA alterations in newborn and adult mouse lung during acute hyperoxia. Exp Lung Res. 1998;24(5):685–702. Epub 1998/10/21. 10.3109/01902149809099588 . [DOI] [PubMed] [Google Scholar]
  • 17.Gerik SM, Keeney SE, Dallas DV, Palkowetz KH, Schmalstieg FC. Neutrophil adhesion molecule expression in the developing neonatal rat exposed to hyperoxia. Am J Respir Cell Mol Biol. 2003;29(4):506–12. Epub 2003/05/06. 10.1165/rcmb.2002-0123OC . [DOI] [PubMed] [Google Scholar]
  • 18.Li XB, Gu JD, Zhou QH. Review of aerobic glycolysis and its key enzymes—new targets for lung cancer therapy. Thoracic cancer. 2015;6(1):17–24. Epub 2015/08/15. 10.1111/1759-7714.12148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Balin AK, Goodman BP, Rasmussen H, Cristofalo VJ. The effect of oxygen tension on the growth and metabolism of WI-38 cells. Journal of cellular physiology. 1976;89(2):235–49. Epub 1976/10/01. 10.1002/jcp.1040890207 . [DOI] [PubMed] [Google Scholar]
  • 20.Bassett DJ, Bowen-Kelly E. Pyruvate metabolism of perfused rat lungs after exposure to 100% oxygen. J Appl Physiol (1985). 1986;60(5):1605–9. Epub 1986/05/01. 10.1152/jappl.1986.60.5.1605 . [DOI] [PubMed] [Google Scholar]
  • 21.Bassett DJ, Bowen-Kelly E, Reichenbaugh SS. Rat lung glucose metabolism after 24 h of exposure to 100% oxygen. J Appl Physiol (1985). 1989;66(2):989–96. Epub 1989/02/01. 10.1152/jappl.1989.66.2.989 . [DOI] [PubMed] [Google Scholar]
  • 22.Bassett DJ, Reichenbaugh SS. Tricarboxylic acid cycle activity in perfused rat lungs after O2 exposure. Am J Physiol. 1992;262(4 Pt 1):L495–501. Epub 1992/04/01. 10.1152/ajplung.1992.262.4.L495 . [DOI] [PubMed] [Google Scholar]
  • 23.Das KC. Hyperoxia decreases glycolytic capacity, glycolytic reserve and oxidative phosphorylation in MLE-12 cells and inhibits complex I and II function, but not complex IV in isolated mouse lung mitochondria. PLoS One. 2013;8(9):e73358 Epub 2013/09/12. 10.1371/journal.pone.0073358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lee SJ, Zhang J, Choi AM, Kim HP. Mitochondrial dysfunction induces formation of lipid droplets as a generalized response to stress. Oxidative medicine and cellular longevity. 2013;2013:327167 Epub 2013/11/01. 10.1155/2013/327167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Schoonen WG, Wanamarta AH, van der Klei-van Moorsel JM, Jakobs C, Joenje H. Respiratory failure and stimulation of glycolysis in Chinese hamster ovary cells exposed to normobaric hyperoxia. The Journal of biological chemistry. 1990;265(19):1118–24. Epub 1990/07/05. . [PubMed] [Google Scholar]
  • 26.Simon LM, Raffin TA, Douglas WH, Theodore J, Robin ED. Effects of high oxygen exposure on bioenergetics in isolated type II pneumocytes. Journal of applied physiology: respiratory, environmental and exercise physiology. 1979;47(1):98–103. Epub 1979/07/01. 10.1152/jappl.1979.47.1.98 . [DOI] [PubMed] [Google Scholar]
  • 27.Zhang Y, Shan P, Srivastava A, Li Z, Lee PJ. Endothelial Stanniocalcin 1 Maintains Mitochondrial Bioenergetics and Prevents Oxidant-Induced Lung Injury via Toll-Like Receptor 4. Antioxid Redox Signal. 2019;30(15):1775–96. Epub 2018/09/07. 10.1089/ars.2018.7514 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Allen CB, Guo XL, White CW. Changes in pulmonary expression of hexokinase and glucose transporter mRNAs in rats adapted to hyperoxia. Am J Physiol. 1998;274(3 Pt 1):L320–9. Epub 1998/04/08. 10.1152/ajplung.1998.274.3.L320 . [DOI] [PubMed] [Google Scholar]
  • 29.Lingappan K, Srinivasan C, Jiang W, Wang L, Couroucli XI, Moorthy B. Analysis of the transcriptome in hyperoxic lung injury and sex-specific alterations in gene expression. PLoS One. 2014;9(7):e101581 Epub 2014/07/09. 10.1371/journal.pone.0101581 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ch Ratnasekhar

29 Jul 2020

PONE-D-20-17370

Difference in pyruvic acid metabolism between neonatal and adult mouse lungs exposed to hyperoxia

PLOS ONE

Dear Dr. Fumihiko Namba,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Though it is a revised submission, it has been assigned to new editor with a new manuscript number due to the fact that the revision has not been submitted on time. I could see reviewer comments and your revised version of the manuscript with all your modifications and responses. For a strong third opinion, I have sent it to another reviewer, who had revised it and asked for minor revision. 

I would be thankful to you if you could revise the manuscript and submit it for consideration. 

Please submit your revised manuscript by Sep 12 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Ch Ratnasekhar, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please ensure you have thoroughly discussed any potential limitations of this study within the Discussion section, including the limited sample size.

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The reviewed study entitled: “Difference in pyruvic acid metabolism between

neonatal and adult mouse lungs exposed to hyperoxia” by Tanaka et al. used CE TOFMS to

investigate the metabolic changes between hyperoxia in neonatal and adult mice. The analytical methods are sound and very well described in the manuscript. This is an interesting study and technique and the results will provide valuable information into using neonatal mice to investigate metabolic changes associated with respiratory exposures and disease.

Minor Comments:

1. In the final paragraph of the introduction on page three, the author should include some references on using CE TOFMS as an analytical tool for metabolomics. This would validate the technique and inform the readers on the how the technique was previously used.

2. Were any of the metabolites confirmed through MS/MS analysis combined with spectral library searching, or were they identified based on intact mass and electrophoresis? If they were only identified based on these 2 parameters, the author should include some information on the mass accuracy of the instrumentation used for the analysis and the mass error for the metabolite in parts per million (ppm).

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Sep 3;15(9):e0238604. doi: 10.1371/journal.pone.0238604.r003

Author response to Decision Letter 0


3 Aug 2020

Ch Ratnasekhar, Ph.D.

Academic Editor

PLOS ONE

1160 Battery Street, Koshland Building East, Suite 225

San Francisco, CA 94111, United States

Aug 03, 2020

Re: Manuscript ID PONE-D-20-17370

Dear Dr. Ch Ratnasekhar,

Please find attached a revised version of our manuscript entitled “Difference in pyruvic acid metabolism between neonatal and adult mouse lungs exposed to hyperoxia”, for publication as an Original Article in PLOS ONE.

Your comments and those of the reviewer were highly insightful and enabled us to greatly improve the quality of our manuscript. In the following pages are our point-by-point responses to each of the comments. Revisions in the text are shown using underline for additions, and strikethrough for deletions. We have deleted Ms. Kikumi Matsuoka’s name as an author and put her name in the Acknowledgement section.

We hope that the manuscript is now suitable for publication in PLOS ONE.

We look forward to hearing from you.

Yours sincerely,

Fumihiko Namba, M.D., Ph.D.

Chief for Research

Center for Maternal, Fetal and Neonatal Medicine

Associate Professor of Pediatrics

Saitama Medical Center, Saitama Medical University

Journal Requirements:

1. Please ensure that your manuscript meets PLOS ONE’s style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We edited our manuscript according to PLOSOne formatting sample provided.

2. Please ensure you have thoroughly discussed any potential limitations of this study within the Discussion section, including the limited sample size.

We have discussed potential limitations of this study within the Discussion section.

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files.

We have provided our original uncropped and unadjusted blot/gel image data are in Supporting Information.

Reviewer(s)' Comments to Author:

Reviewer #1: The reviewed study entitled: “Difference in pyruvic acid metabolism between neonatal and adult mouse lungs exposed to hyperoxia” by Tanaka et al. used CE TOFMS to investigate the metabolic changes between hyperoxia in neonatal and adult mice. The analytical methods are sound and very well described in the manuscript. This is an interesting study and technique and the results will provide valuable information into using neonatal mice to investigate metabolic changes associated with respiratory exposures and disease.

Minor Comments:

1. In the final paragraph of the introduction on page three, the author should include some references on using CE TOFMS as an analytical tool for metabolomics. This would validate the technique and inform the readers on the how the technique was previously used.

As Reviewer recommended, references that reviews CE-TOFMS technique and that is using CE TOFMS are added.

2. Were any of the metabolites confirmed through MS/MS analysis combined with spectral library searching, or were they identified based on intact mass and electrophoresis? If they were only identified based on these 2 parameters, the author should include some information on the mass accuracy of the instrumentation used for the analysis and the mass error for the metabolite in parts per million (ppm).

We did not perform MS/MS. We identified metabolite based on intact mass and migration time in capillary electrophoresis. We assigned metabolite names by matching with the library created by measurement of reference material. Mass error was limited within ±10ppm of theoretical value and migration tome was limited within ±0.5 minutes of the library.

Attachment

Submitted filename: Answer-to-Reviewers-Comments073020-edit-KT.docx

Decision Letter 1

Ch Ratnasekhar

20 Aug 2020

Difference in pyruvic acid metabolism between neonatal and adult mouse lungs exposed to hyperoxia

PONE-D-20-17370R1

Dear Dr. Namba,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ch Ratnasekhar, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Ch Ratnasekhar

24 Aug 2020

PONE-D-20-17370R1

Difference in pyruvic acid metabolism between neonatal and adult mouse lungs exposed to hyperoxia

Dear Dr. Namba:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ch Ratnasekhar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Metabolomic data map of the all metabolic pathway detected in the neonatal and adult mouse lungs.

    For all metabolite graphs, the vertical axis shows the detected average value with standard deviation (error bar) for each comparative group, and the groups are arranged from the left in the following order: room air newborn (blue), high O2 concentration newborn (bright red), room air adult (purple), and high O2 concentration adult groups (light red). All metabolic data are presented as means ± standard deviation from biological triplicate samples.

    (PPTX)

    S2 Fig

    (JPG)

    S3 Fig

    (JPG)

    S1 Table. Factor loadings of the principal component analysis (PCA).

    Metabolites constituting glycolysis-citric acid circuit are highlighted with grey background.

    (XLSX)

    Attachment

    Submitted filename: Answer-to-Reviewers-Comments052520.docx

    Attachment

    Submitted filename: Answer-to-Reviewers-Comments073020-edit-KT.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES